| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/29/2013 | CN102125559B Pharmaceutical composition containing pentoxifylline and carbazochrome sodium sulfonate and application thereof |
| 05/29/2013 | CN102112119B Diaryl hepatonoid-based compound useful as virus inhibitor |
| 05/29/2013 | CN102088988B Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 05/29/2013 | CN102066369B Bromo-phenyl substituted thiazolyl dihydropyrimidines |
| 05/29/2013 | CN102066327B Iminopyridine derivatives and use thereof |
| 05/29/2013 | CN102050801B Method for preparing arylpiperazines derivative optical isomer |
| 05/29/2013 | CN102050733B Biphenyl cyclooctene type lignan compound and medicinal application thereof |
| 05/29/2013 | CN102038644B Lutein water-soluble powder and preparation process thereof |
| 05/29/2013 | CN102026664B Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 05/29/2013 | CN102018832B Weight-reducing composition and preparation method thereof |
| 05/29/2013 | CN102008459B Antibacterial agents |
| 05/29/2013 | CN101982467B Lignans compounds contained in Schisandra chinensis, and preparation method and application thereof |
| 05/29/2013 | CN101981013B Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
| 05/29/2013 | CN101973883B Phenolic compound in tobaccos and preparation method and application thereof |
| 05/29/2013 | CN101970429B 2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace) |
| 05/29/2013 | CN101967127B Quinazoline derivative and preparation method thereof and application of quinazoline derivative for preparing anticancer drugs |
| 05/29/2013 | CN101925355B Fentanyl-containing patch for external use |
| 05/29/2013 | CN101917977B Formulations of nonopioid and confined opioid analgesics |
| 05/29/2013 | CN101909628B Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 05/29/2013 | CN101891706B 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same |
| 05/29/2013 | CN101883557B Novel thermosensitive liposomes containing therapeutic agents |
| 05/29/2013 | CN101883556B Transdermal delivery system for hormones and steroids |
| 05/29/2013 | CN101878213B Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 05/29/2013 | CN101875945B Avermectin aglycon synthase genes |
| 05/29/2013 | CN101868472B Antibacterial aminoglycoside analogs |
| 05/29/2013 | CN101861301B Dioxoanthracene sulphonate derivatives |
| 05/29/2013 | CN101856398B Detection method of Chinese medicinal composition for clearing heat and cooling blood, promoting blood circulation and stopping pain |
| 05/29/2013 | CN101851247B Composition containing clopidogrel bisulfate crystal particles |
| 05/29/2013 | CN101835765B Alkylsulfonyl-substituted thiazolide compounds |
| 05/29/2013 | CN101830894B Benzo[d]oxazole compounds and preparation method thereof |
| 05/29/2013 | CN101812491B Method for producing pleurotus ferulae polysaccharide and oral liquid thereof through fermentation |
| 05/29/2013 | CN101805699B Method for preparing gliocladicillin C and application thereof |
| 05/29/2013 | CN101791300B Acipimox push-pull osmotic pump controlled release tablet and preparation method thereof |
| 05/29/2013 | CN101730701B Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 05/29/2013 | CN101730533B Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 05/29/2013 | CN101721422B Medicine for treating arthritis and preparation method thereof |
| 05/29/2013 | CN101693714B Spirocyclic cyclohexane derivatives |
| 05/29/2013 | CN101687849B Crystalline forms of solvated ilaprazole |
| 05/29/2013 | CN101669934B application of mango aglycone in preparing medicine for obesity |
| 05/29/2013 | CN101646674B Indolobenzazepine derivatives for the treatment of hepatitis c |
| 05/29/2013 | CN101646358B Food supplement containing alpha-keto acids |
| 05/29/2013 | CN101641093B Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 05/29/2013 | CN101636168B Sp35 antibodies and uses thereof |
| 05/29/2013 | CN101628911B Antibiotic drug |
| 05/29/2013 | CN101622254B Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 05/29/2013 | CN101616669B Preparation of medicine for the treatment of alcohol abuse, addiction and dependency |
| 05/29/2013 | CN101613266B Monohydroxy conjugated linoleic acid, preparation method and application thereof |
| 05/29/2013 | CN101597230B Beta,beta-dimethyl-acry-lalkannin and application in preparing medicines for inhibiting drug-resistant bacteria |
| 05/29/2013 | CN101594780B Agents for controlling parasites on animals |
| 05/29/2013 | CN101565359B Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 05/29/2013 | CN101553491B Quinoxaline derivative |
| 05/29/2013 | CN101553233B Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/29/2013 | CN101531644B New daphnane diterpene compounds in Daphne genkwa as well as preparation method and application of same |
| 05/29/2013 | CN101528199B 改良的鼻烟组合物 Improved snuff composition |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/29/2013 | CN101502656B Composition for eliminating bitter taste of soluble and stable macrolides medicament |
| 05/29/2013 | CN101490023B Modulators of pharmacokinetic properties of therapeutics |
| 05/29/2013 | CN101466710B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/29/2013 | CN101434593B Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/29/2013 | CN101429185B Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/29/2013 | CN101417937B Beta-aldehyde ketones antibacterial compounds and use thereof |
| 05/29/2013 | CN101417081B Quality detection method of Longfengbao capsule |
| 05/29/2013 | CN101407514B Tiotropium salts, tiotropium salts pharmaceutical formulations and uses thereof |
| 05/29/2013 | CN101395147B 1-(benzo (d) (1,3) dioxol-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis |
| 05/29/2013 | CN101394860B Inhibition of inflammatory cytokine production with tanshinones |
| 05/29/2013 | CN101394850B Orodispersible domperidone tablets |
| 05/29/2013 | CN101384575B Tiglien-3-one derivatives |
| 05/29/2013 | CN101370804B Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/29/2013 | CN101331128B Novel forms of tiotropium bromide and processes for preparation thereof |
| 05/29/2013 | CN101322734B Codonopsis lanceolata total saponins with anti-inflammatory immunity function and preparation thereof |
| 05/29/2013 | CN101287443B Pulse releasing system controlled by pH, preparation method and application thereof |
| 05/29/2013 | CN101235041B Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof |
| 05/29/2013 | CN101225424B Single-glucopyranoside of cyclomembranousol, preparation method, medicament combination and uses thereof |
| 05/29/2013 | CN101217972B Method for fostering bone formation and preservation |
| 05/29/2013 | CN101193641B Compositions and methods for treating hyperproliferative epidermal diseases |
| 05/29/2013 | CN101184734B Compound and methods of treating cell proliferation disorders |
| 05/29/2013 | CN101090902B Cgrp受体拮抗剂 Cgrp receptor antagonist |
| 05/29/2013 | CN101022808B Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 05/29/2013 | CN101010086B Ceramide derivatives as modulators of immunity and autoimmunity |
| 05/28/2013 | US8450525 Histone deacetylase inhibitors |
| 05/28/2013 | US8450522 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 05/28/2013 | US8450506 Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field |
| 05/28/2013 | US8450500 Pyrrole compounds that modulate HSP90 activity |
| 05/28/2013 | US8450494 Disubstituted benzamide derivatives as glucokinase (GK) activators |
| 05/28/2013 | US8450491 Method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
| 05/28/2013 | US8450486 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 05/28/2013 | US8450483 Pesticidal arylpyrrolidines |
| 05/28/2013 | US8450481 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 05/28/2013 | US8450479 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their use |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450459 IL-21 derivatives and variants |
| 05/28/2013 | US8450379 Methods for treating migraine |
| 05/28/2013 | US8450378 Antiviral method |
| 05/28/2013 | US8450377 1-adamantyl chalcones for the treatment of proliferative disorders |
| 05/28/2013 | US8450376 Amorphous bupropion hydrobromide and preparation thereof |
| 05/28/2013 | US8450375 Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 05/28/2013 | US8450374 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| 05/28/2013 | US8450373 Alpha ketoamide compounds as cysteine protease inhibitors |
| 05/28/2013 | US8450372 Formulations of suberoylanilide hydroxamic acid and methods for producing same |